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Abstract
Bisphenol-A (BPA) is a structural component in many plastic products, which acts as
an endocrine-disruptor mimicking estrogen. This hormonal disruption has been linked to
obesity, reproductive issues, cardiovascular problems, and neurodevelopment disorders.
Infants are at the highest risk of BPA exposure compared to any other stage of life. Because
an infant’s endocrine system is developing, exposure to an endocrine-disruptor, such as BPA,
can be especially harmful. While the FDA monitors products like baby bottles, canned goods,
and plastic containers for BPA, infant oral hygiene products are not closely monitored.
Previous research in our lab used fluorescence spectroscopy to test several brands of
infant toothbrushes and found that many contain and leach BPA into their surroundings.
Bisphenol-A fluoresces at an excitation wavelength of 278 nm and an emission wavelength
of 304 nm. When tested at the average body temperature, 37 °C, research showed an
increased amount of BPA leaching from the toothbrushes. For this project, toothbrushes were
tested by storing them at higher temperatures, 50 °C, prior to testing for time increments
similar to that of shipment in semi-trucks. Large shipments spend an average of 3-7 days in
semi-truck containers, and the shipment temperature, on average, reaches 50 °C.
Toothbrushes were then placed in 1:1 methanol/water for several hours. Aliquots were
removed over time, and the amount of BPA leaching from the samples was monitored using
an FS5 Spectrofluorometer from Edinburgh instruments. The results of this experiment
revealed an insignificant increase in the amount of BPA leaching out of toothbrushes at
increased duration and temperature.

Bynum 4

Introduction
Bisphenol A (BPA) is a man-made monomer used in the synthesis of polycarbonate
and epoxy resins. This synthetic chemical has been in use since the 1940s for flame
retardants, can linings, and hard plastics, such as baby bottles and sippy cupsxv. The usage of
BPA, and its analogues, in plastics has been a focus for many researchers in sustainable and
environmental chemistry. The increase in plastic waste raises concerns over the physiological
and environmental effects of the chemicals utilized in plastics. Research into the upcycling of
BPA from bisphenol A carbonate (BPA-PC) shows promising results to combat the
environmental pollution brought by BPAxxix. Further research has been performed to show
the concentrations of BPA in canned foods and baby itemsxiii. To continue the research into
the concentration of BPA in baby items, this research will investigate the concentrations of
BPA in infant oral hygiene products and the effects of exposure to this endocrine-disrupting
compound.
While BPA is industrially beneficial, BPA is a known endocrine disruptor, mimicking
estradiol, the precursor to estrogen. This hormonal disruption has been linked to obesity,
reproductive issues, cardiovascular problems, and neurodevelopment disordersvii. Due to this
health threat, the Food and Drug Administration (FDA) has placed industrial regulations on
the usage of BPA. This regulation, however, does not prevent the usage of BPA in infant oral
hygiene products.
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Molecularly, BPA consists of two benzene rings, two hydroxide groups, and two
methyl groups. Due to the terminal hydroxide groups, BPA acts as a competitive inhibitor for
estradiol (Figure 1). The hydroxide functional groups on BPA bind to the estrogen receptors
in place of estradiol. This signals to other tissues the incorrect concentration of estrogen
within the body. Ultimately, BPA inhibits the production of estrogen, disrupting functions in
the endocrine system.

Figure 1. Chemical structures of BPA (top) and estradiol (bottom). Both compounds contain a
phenol group (blue), which can react with estrogen receptors.
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On average, an adult intakes 30 to 70 ng/kg of body weight of BPA per day, while an
infant intakes 300 to 500 ng/kg of body weight of BPA per dayxviii. While both these
concentrations are lower than the FDA-determined tolerable daily intake (TDI), 5 μg/kg-day,
the effects of BPA make an identifiable impact to the health of adults and infants. The FDA
found that BPA is primarily ingested orally, in which BPA is quickly metabolized into an
inactive form. The TDI was determined based on this mechanism and accounts for the gap in
the average intake and tolerable intakeviii. Infants, however, may ingest 100 times more BPA
per body weight compared to the rest of the population. This high concentration is due to the
widespread exposure from infant formula, breast milk from the mother carrying
concentrations of BPA, pacifiers, oral hygiene products, and more. The endocrine system of
an infant is not fully developed; therefore, this increased exposure is especially harmful.
Prolonged BPA exposure has been linked to many health issues.
In the United States, the distribution industry never stops. Shipments are exposed to a
wide range of uncontrolled temperatures for the duration of the delivery time, an average of
three to seven days. Depending on the materials of the shipping container, the inside
temperature of a shipping container can rise to 15 °C higher than the ambient temperature.
With US ambient temperature reaching as high as 43 °C, this increases the temperature of the
internal environment to 58 °C, or 136.4 °Fxvi. This is a cause for concern, since at 25 °C,
BPA releases at 0.62-22.5 ng/L and at 70 °C, BPA releases at 2.89-38.9 ng/Lvii. Furthermore,
BPA release rate increases for a period of four weeks in storage, then stabilizes in long term
storage. Exposure to the uncontrolled temperatures during shipment and storage causes BPA
to break down and release from plastics products, such as infant oral hygiene products, at an
increased rate.
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From previous research, BPA leaches from infant toothbrushes during storage at room
temperature, under oral conditions, and during usagexxiii. As infant oral hygiene products and
toothbrushes travel in shipment containers across the US, they are exposed to intense heat
during the three-to-seven-day delivery time. This significantly increases the risk of BPA
leaching from the toothbrushes. Because of the long-term health effects of BPA on the
endocrine system, this risk directly concerns infants.

Health Effects of BPA- Neurodevelopmental
Environment and genes both directly affect an individual’s neurodevelopment and
their susceptibility to neurodevelopmental disabilities. 17β-estradiol (E2) is the hormone
often referred to as estrogenxxvii. The synthesis of E2 follows the steroidogenic pathway
within the brainxxvii. This pathway converts cholesterol to testosterone via enzymes, then
aromatizes testosterone via aromatase to 17β-estradiol. However, female fetal ovaries do not
produce E2 until after birth. In both male and female fetal brains, E2 can also be produced
through the metabolization of dihydrotestosterone (DHT) to 3βAdiolxxvii. During gestation,
the primary form of circulating estrogen that encourages neurodevelopment is 3βAdiol. For
hormones to be effective, they require a receptor. In the case of 17β-estradiol and 3βAdiol,
the receptors are estrogen receptor alpha, ERα, and estrogen receptor beta, ERβ; 3βAdiol will
primarily bind to ERβxxvii. ERβ is widely distributed in the brain. Specifically, ERβ is
distributed in the “hippocampus, cerebral cortex, dorsal raphe, substantia nigra, amygdala,
microglia, and oligodendrocytes” xxvii. Therefore, ERβ is the main estrogen regulator
associated with cognitive and affective behaviors.
The mechanisms behind the relationship between the estrogen regulator and behavior
is associated to other hormones, serotonin and dopamine. Serotonergic neurons express ERβ,
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where it mediates the rate limiting enzyme for serotonin synthesis, E2-dependent tryptophan
hydroxylase (TPH) xxvii. In the substantia nigra, dopamine is produced. ERβ is the main
estrogen receptor isoform, resulting in the promotion of neuroprotection of dopaminergic
neurons via 17β-estradiol (E2).
Furthermore, ERβ has been connected to DNA de-methylation, which is an important
pathway in embryonic development and differentiation. In DNA de-methylation, ERβ
functions at different levels during neurodevelopment primarily by two mechanisms:
promoting gene transcription or directing the mechanism to different gene regulatory
regionsxxvii. Genes CYP19A1 and DYX1C1 potentially link the two components. In normal
gene regulation, the aromatase enzyme converts testosterone to E2 and is encoded by
CYP19A1. Researchers currently hypothesize that when the CYP19A1 gene is dysregulated,
due to mutation or environment, aromatase does not convert androgens to E2, causing
overexposure of the brain to androgensxxvii. This increase in testosterone promotes apoptosis
in the right brain hemisphere and slows the development of the left hemisphere xxvii.
Ultimately, as the levels of testosterone increase in an individual, the risk increases for a
neurodevelopmental disability. In relation to the DYX1C1 gene, ERβ and DYX1C1 genes
are associated through feedback regulation. ERβ promotes transcription of the gene when E2
is present, and DYX1C1 promotes proteasomal degradation of ERsxxvii. This association
shows the impact of the endocrine system on the expression of DYX1C1. Both components,
environment and genetics, play important roles in the development of a fetus’ neural system.
Neurodevelopmental disorders are “disabilities associated primarily with the
functioning of the neurological system”iv. These disabilities include attentiondeficit/hyperactivity disorder (ADHD), autism, learning disabilities, intellectual disabilities,
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conduct disorders, cerebral palsy, and impairments in vision and hearingiv. Neurodevelopmental disorders affect many adults and children. Globally, 6.7 % of the population,
ranging 5-17 years old, is diagnosed with a neurodevelopmental disorder. In the past decade,
the percentage of children diagnosed with ADHD, specifically, has increased by 4.4%xxvi. On
average, in a US class, one in five students has a neurodevelopmental disorderxxv. With many
stigmas surrounding neurodevelopmental disabilities, these students are often overlooked and
underserved.
These neurodevelopmental abilities have many potential genetic components but are
also affected by the environmental components. As mentioned earlier, disruption in the gene
CYP19A1 increases the levels of testosterone. High levels of testosterone alter the
hemispheric lateralization of the brain and put the individual at an increased risk for dyslexia
and ADHDxxvii. Fetal female ovaries, however, protect the fetus from the loss of local E2
production. Prevalence rates of dyslexia further support this as males are more often affected
than females in almost all intellectual and developmental disabilities. DYX1C1 is associated
with neural abnormalities, such as cortical ectopias and heterotopias, which are common
attributes of a human dyslectic brainxxvii. The increased levels of testosterone dysregulate the
DYX1C1 expression and could predispose an individual to ADHD. The genomic location of
these two genes contains areas susceptible to ADHDxxvii.
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Figure 2. Genetic regulation model showing how
BPA effects the interaction with DYX1C1 gene
expressionxxvii.
Environmental exposures, such as endocrine-disrupting compound (EDC), affect
developing neuroendocrine systems. To further compound these effects, environmental
stressors such as socioeconomic hardship and poor parental behavior can greatly increase a
child’s exposure to EDCsxvix. Because of the steroidogenic mechanism and its systemic
effects, estrogen, E2, helps protect the brain in all stages of life. Disruption of this
mechanism from EDCs can lead to neurodevelopmental consequences. Endocrine imbalances
created by aromatase dysregulation and EDCs heavily impact DYX1C1 expression (Figure
2). Bisphenol A is a major EDC used in hard plastics and epoxy resins. As mentioned earlier,
Bisphenol A has been associated with a variety of health problems following exposure, due
to its endocrine disrupting properties. Neurodevelopmental disorders have increased in
prevalence over the past decades, which coincides with the significant increase in BPA
exposure. The research performed on the link between estrogen and neurodevelopment
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shows a positive correlation between endocrine-disrupting compounds and
neurodevelopmental disordersxxvii.
Based on the research over the neurodevelopmental effects of endocrine disrupting
compounds (EDCs), specifically BPA, many companies have attempted to create
replacement analogues of BPA. These include Bisphenol S (BPS), Bisphenol AF (BPAF),
Bisphenol C (BPC), Bisphenol E (BPE), Bisphenol FL (BPFL), and Bisphenol Z (BPZ) xii.
Because of the structural similarity to estrogen, these analogues present similar or higher
toxic biological effects than BPA. Bisphenol S, specifically, can be detected in fetal cord
blood, meaning it crosses the placental barrierix. Bisphenol S does not show estrogenic
activity but does show progestogenic activity. While this BPA analogue is greatly underresearched, the same basic problem remains; exposure to Bisphenol S negatively impacts
placental developmental and endocrine function.
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Fluorescent Spectroscopy
Fluorescent spectroscopy is a useful method for determining the distribution of small
molecules within a solutioniii. Both excitation
and emission spectrums can provide important
information about a chemical solution.
Absorption wavelengths and emission
wavelengths are independent of each otherxxviii.
Therefore, these two spectrums are uniquely
individual in their technics for analyzing
chemical substances. Absorption occurs when an
electron transfers to a higher energy level state
by absorbing the light energy at a specific
wavelength (Figure 3)iii. This spectrum

Figure 3. The Jablonski Diagram. Used as a
model in Florescence Spectroscopy to
illustrate the absorption versus emission in
relation to energy levelsiii.

shows the excitation intensities. Absorption is a strong experimental technique when
impurities are removed. In this experiment, however, impurities were not removed due the
delicacy of BPA in solution. Due to this, an emission spectrum was more effective in the
solution analysis. The emission spectrum was measured on the FS5 Spectrofluorometer from
Edinburgh instrument as electrons were transferred to a lower energy level, releasing energy
in the form of photons at a specific wavelength (Figure 4). This experiment utilized emission
intensities because BPA is fluorescent and will release photons while falling from a higher
energy level to a lower energy level. This is measured by sending the excitation light at a
90 ° angle to the samplei. Furthermore, the emission spectrums will be polychromatic as the
emission light spreads across many wavelengthsxxviii. The emission intensities are averaged
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per sample. These average emission intensities were correlated to varying concentrations of
BPA via a calibration curve.
Based on the calibration curve, the excitation wavelength was 278 nm, and the
emission wavelength was 304 nm (Figure 5). Fluorescent spectroscopy was utilized to
measure the emission intensities from concentrations of BPA in solution.
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Figure 4. Edinburgh Instruments Spectrofluorometer. Instrument used to measure emission
intensities of solutions containing BPAxxiii.

Figure 5. Fluorescence Excitation and Emission spectra obtained using the FS5
Spectrofluorometer from Edinburgh Instruments. The excitation wavelength is on the left
(around 278 nm) and the emission wavelength is on the right (around 304 nm)xxiii.
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Materials/Methods
This experiment utilized the following chemicals: Bisphenol-A (BPA), HPLC water,
HPLC methanol, and HPLC nitric acid. Glassware included 10-mL volumetric flasks, 5-ml
volumetric flasks, 100-ml beakers, six watch glasses, and three 5-mL pipettes. Between
experimental trials, all glassware was washed three times with a 25% nitric acid-water
solution, rinsed three times with distilled water, then three times with Milli-Q water. Two
instruments were used for this
experiment. First, emissions intensities
were determined via fluorescence using
the FS5 Spectrofluorometer from
Edinburgh Instruments. Second, the
controlled shipment conditions were
generated by the Shake’N’Bake
Hybridization Oven from Boekel
Scientific (Figure 6). Three toothbrush
brands-Colgate, Baby’s First Toothbrush,
and Dollar General-of varying BPA
concentrations, confirmed through past
research, were tested in this experiment.

Figure 6: Shake’N’Bake Hybridization
Oven from Boekel Scientific. Used to
generate shipment environment.

Additional materials, such as gloves, goggles, labels, and parafilm, were used for safety
measures, minimizing errors, and preventing evaporation or contamination of the samples.
To correlate emission intensities and BPA concentration, a calibration curve was
created. Bisphenol A was measured to 0.203 g, then dissolved in 100-mL volumetric flask
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with a 1:1 methanol water solution. This stock solution was then serially diluted across 12
25-mL volumetric flasks. The volumes of BPA solution were 0 mL, 1 mL, 2 mL, 3 mL, 4
mL, 5 mL, 7 mL, 10 mL, 13 mL, 15 mL, 20 mL, and 25 mL. Each volume was diluted to a
total volume of 25 mL. The final concentrations were 0 mM, 2.06 mM, 4.13 mM, 6.19 mM,
8.26 mM, 10.32 mM, 14.44 mM, 20.64 mM, 26.83 mM, 30.96 mM, 41.28 mM, and 51.6
mM. For the fluorescence measurements, each sample was measured in quintuplicate. The
excitation wavelength was set to 278 nm and the emission wavelength at 304 nm. From the
calibration curve, the linear range of measurable fluorescence was determined to be between
0-20 μg/mL. The limit of detection was 0.109 μg/mL, and the limit of quantification was
0.363 μg/mL (Figure 7). The FS5 Spectrofluorometer measured the excitation and emission
intensities of the varying concentration of BPA in solution.
This experimental control was repeated at 50 °C to test if BPA concentration would
be affected by temperature. To do this, samples of varying concentration were placed in a
water bath at 50 °C for 1 hour. After the solutions were warmed to 50 °C, the fluorescence
was measured again in the same manner, then compared to the standard curve at room
temperature.
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Figure 7: Fluorescence calibration curves of BPA in 1:1 M/W
solution obtained at 20 °C and 50 °C.
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Three infant toothbrush brands were tested in this experiment. The Control Group
was a BPA-free toothbrush, confirmed through previous research. Toothbrush “A” and “B”
contain BPA. Previous research showed Toothbrush A containing the highest concentration
of BPA of several brands. Toothbrush B was chosen from a mid-level concentration of BPA
from previous research. The toothbrushes were labeled accordingly to minimize errors.
The experimental plan for the toothbrushes consisted of time in the Shake’N’Bake
and time in 1:1 methanol water solution. Each experimental toothbrush was baked at 50 °C
for 3, 5, and 7 days; this provided conditions similar to a shipment container. In addition to
the labels “Control,” “A,” and “B,” the toothbrushes were also labeled according to bake
time in days. The full label would then include days:group, i.e., 3A. After the allotted bake
time, the toothbrushes were placed in 100 mL of 1:1 methanol water solution at room
temperature (20 °C). Using the 5 mL pipette, 5 mL samples were removed at 0 min, 5 min,
10 min, 15 min, 20 min, 40 min, 60 min, 80 min, 100 min, 120 min, 4 hrs, 5 hrs, 6 hrs, 8 hrs,
24 hrs, 48 hrs, and 72 hrs. These samples were run in duplicate in FS5 Spectrofluorometer,
measuring the peak emission intensities. Emission intensities were measured in counts per
second (cps). This was repeated twice for each toothbrush to confirm results.
All collected data was entered into Excel, where the data was graphed and analyzed.
For statistical analysis, the emission intensities were compared through ANOVA between
groups (Control, A, B) and days (3, 5, 7). The analysis compared data at a .05 level of
significance.
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Results and Discussion
Using ANOVA, the emission intensities were compared by bake time and by brand. The
graphs compare the emission intensities to the time in solution after the allotted bake time.
Average emission intensities were graphed versus time for the control environment from all
toothbrushes prior to baking. For the Control Group, the average intensity over time was
3.80E03 cps (SD=1606.85). Toothbrush A’s emission intensities averaged at 3.56E03 cps
(SD=1106.12), and Toothbrush B’s emission intensities averaged at 4.12E03 cps
(SD=1694.39) (Figure 8). The ANOVA found that there was no significant difference
between the toothbrush brands in the control (20 °C) environment, 6.07E-01(17, 17) = 0.605,
p > .05 (Table 1).
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Figure 8: Average fluorescence emission intensities of No Bake
Control vs Toothbrush A vs Toothbrush B
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Figure 9: Average fluorescence emission intensities of 3 Day Bake
Control vs Toothbrush A vs Toothbrush B

After three days under shipment conditions, the Control Group had emission intensities
averaging 3.73E03 cps (SD=1657.26). The emission intensities of Groups A and B averaged
4.17E03 cps (SD=1955.7) and 3.88E03 cps (SD=1383.08), respectively (Figure 9). There
6.07E-01(17, 17) = 0.605, p > .05 was no significant difference in the amount of BPA
leaching from the infant toothbrushes at 50 °C over three days, 2.88E-01(17,17) =0.400, p
> .05 (Table 1).
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Figure 10: Average fluorescence emission intensities of 5 Day Bake
Control vs Toothbrush A vs Toothbrush B

For the five-day shipment trial, the emission intensity average of the Control Group
was 3.81E03 cps (SD=1612.28). The average emission intensity of Toothbrush A was
4.28E03 cps (SD=1808.77) and Toothbrush B was 4.12E03 cps (SD=1799.27) (Figure 10).
There was no significant difference in the amount of BPA leaching from the infant
toothbrushes at 50 °C over 5 days, 3.13E-01(17,17) = 0.392, p > .05 (Table 1).
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Figure 11: Average fluorescence emission intensities of 7 Day Bake
Control vs Toothbrush A vs Toothbrush B

Finally, when placed in shipment condition for seven days, the emission intensity of
the Control Group averaged at 3.44E03 cps (SD=1280.63). The emission intensities of
toothbrushes A and B averaged at 3.63E03 cps (SD=1312.88) and 3.409E03 cps
(SD=1470.03), respectively (Figure 11). The ANOVA revealed there was no significant
difference in the amount of BPA leaching from the infant toothbrushes at 50 °C over 7 days,
2.06E-01(17,17) = 0.419, p > .05 (Table 1).
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F-Value

P-Value

0 Days: Control vs A vs B

0.607

.605

3 Days: Control vs A vs B

0.288

.400

5 Days: Control vs A vs B

0.312

.392

7 Days: Control vs A vs B

0.206

.419

Table 1: Statistical comparison (ANOVA) of fluorescence emission
intensities over time.
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A potential error in this experiment should be noted; these toothbrushes are
approximately five years old. The effect of time on the concentration of BPA within the
toothbrushes was unknown prior to the start of this research. According to previous research,
the release rate of Bisphenol A from plastics decreases to insignificant amounts after four to
five years. Because of the insignificance of the data from the control experiment, in which
the toothbrushes were not under shipment stress, the data presented in this experiment could
be skewed. Further testing would be required to determine the validity of this error.

Conclusion
Based on the results of this experiment, shipment temperature and duration does not
significantly affect the amount of BPA leaching from infant toothbrushes. If accurate, this
information can be comforting to parents of infants, as this shows there is no increase of BPA
released from infant toothbrushes due to shipment. This information does not discount
previous research showing the significant release of BPA from infant toothbrushes.

Future Work
Future research entails retesting with recently manufactured toothbrushes, additional
comparisons with other BPA-containing toothbrushes, and performing this experiment in a
50 °C water bath. The breakdown of BPA in relation to the age of the toothbrushes tested did
affect the results of this experiment. By using recently manufactured toothbrushes, the results
could reveal a different conclusion. Future work could also entail testing the other brands of
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infant toothbrushes containing BPA, as this experiment is limited to only three brands.
Finally, future researcher could benefit from testing the leaching of BPA when the
toothbrushes are under shipment conditions, 50 °C for 3-7 days. By taking samples prior,
during, and shortly after the environmental exposure, the results may reveal BPA to be
significantly leaching within the shipment container. Biologically, further research into the
effects of BPA on neurodevelopment would be potentially pivotal to infantile health.
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Abbreviations
ADHD: Attention-Deficit/Hyperactivity Disorder
ANOVA: Analysis of Variance
BPA: Bisphenol – A
BPAF: Bisphenol AF
BPA-PC: Bisphenol-A Carbonate
BPC: Bisphenol C
BPE: Bisphenol E
BPFL: Bisphenol FL
BPS: Bisphenol S
BPZ: Bisphenol Z
CPS: counts per second
DHT: dihydrotestosterone
E2: 17β-estradiol
EDC: endocrine-disrupting compound
FDA: Food and Drug Administration
SD: Standard Deviation
TDI: Tolerable Daily Intake
TPH: Tryptophan Hydroxylase

Bynum 28

References
i

Anderson, C; Mortensen, G. “Fluorescence Spectroscopy: A Rapid Tool for Analyzing
Dairy Products”. J. Agric Food Chem. 2008, 56, 720-729, DOI: 10.1021/jf072025o.

ii

Durkin, M; “Increasing Prevalence of Developmental Disabilities Among Children in the
US: A Sign of Progress?”. Pediatrics 2019, 144 (4), DOI:10.1542/peds.2019-2005.

iii

Eleftherios P. Diamandis. “Fluorescence Spectroscopy” Analytical
Chemistry 1993 65 (12), 454-459 DOI: 10.1021/ac00060a616

iv

Environmental Protection Agency, United States. “Neurodevelopment Disorders”.
America’s Children and the Environment 2015, 3, 1-32.

v

Eurolog Packing Group. “How hot do shipping containers get?” https://epgna.com/how-hotdo-shipping-containers-get/. 2021.

vii

Fan, Y.; Zheng, J.; Ren J.; Luo, J. Cui, X.; Ma, L. “Effects of storage temperature and
duration on release of antimony and bisphenol A from polyethylene terephthalate
drinking water bottles of China”. Environmental Pollution 2014, 192, 113-120 DOI:
10.1016/j.envpol.2014.05.012.

viii

Federal Drug and Administration; “Bisphenol A (BPA): Use in Food Contact
Application”. Food Additives & Petitions, https://www.fda.gov/food/food-additivespetitions/bisphenol-bpa-use-food-contact-application#Ref6, 2014.

ix

Gingrich, J.; Pu, Y.; Roberts, J.; Karthikraj, R.; Kannan, K.; Ehrhardt, R.; Veiga-Lopez, A.
“Gestational Bisphenol S Impairs Placental Endocrine Function and the Fusogenic
Trophoblast Signaling Pathway”. Archives of Toxicology 2018, 92 (5), 1861–1876
DOI: 10.1007/s00204-018-2191-2.

x

Gore, A. “Introduction to Endocrine Disrupting Chemicals (edcs)”.
https://www.endocrine.org/-/media/endosociety/files/advocacy-andoutreach/important-documents/introduction-to-endocrine-disrupting-chemicals.pdf,
2014.

xi

Herwegen, J.V.; Palikara, O.; Introduction to special issue on neurodevelopmental
disorders in the classroom”. Research in Developmental Disabilities, 2019, 91, 103431 DOI: 10.1016/j.ridd.2019.103431.

xii

Karsauliya, K.; Bhateria, M.; Sonker, A.; Singh, S. P. “Determination of Bisphenol
Analogues in Infant Formula Products from India and Evaluating the Health Risk in
Infants Associated with Their Exposure”. Journal of Agricultural and Food
Chemistry 2021, 69 (13), 3932–3941 DOI: 10.1021/acs.jafc.1c00129.

Bynum 29

xiii

Liao, C; Kannan, K. “Concentrations and Profiles of Bisphenol A and Other Bisphenol
Analogues in Foodstuffs from the United States and Their Implications for Human
Exposure”. Journal of Agricultural and Food Chemistry 2013, 61, 4655-4662 DOI:
10.1021/jf400445n.

xiv

Lind, P. M.; Lind, L. “Endocrine-Disrupting Chemicals and Risk of Diabetes: An
Evidence-Based Review”. Diabetologia : Clinical, Translational and Experimental
Diabetes and Metabolism 2018, 61 (7), 1495–1502 DOI: 10.1007/s00125-018-4621-3

xv

Luttrell, W. E.; Baird, B. A. “Bisphenol A”. Journal of Chemical Health &
Safety 2014, 21 (5), 22–24 DOI: 10.1016/j.jchas.2014.07.011.

xvi

Marquez, L.; Dunstall, S.; Bartholdi, J.; MacCawley, A. “'Cool or Hot': A Study of
Container Temperatures in Australian Wine Shipments”. Australasian Journal of
Regional Studies, The 2012, 18 (3), 420–443.

xvii

Meeker, J. “Exposure to Environmental Endocrine Disruptors and Child
Development”. Arch Pediatric Adolescent Medicine, 2012, 166 (6), E1-E7
DOI:10.1001/archpediatrics.2012.241.

xviii

Mendonca, K.; Hauser, R.; Calafat, A. M.; Arbuckle, T. E.; Duty, S. M. “Bisphenol a
Concentrations in Maternal Breast Milk and Infant Urine”. International Archives of
Occupational and Environmental Health 2014, 87 (1), 13–20 DOI: 10.1007/s00420012-0834-9.

xvix

Ogundele, M.; Morton, Michael. “Classification, prevalence and integrated care for
neurodevelopmental and child mental health disorders: A brief overview for
pediatricians”. National Library of Medicine, 2022, 11 (2), 120-135. DOI:
10.5409/wjcp.v11.i2.120.

xx

Shareef, A.; Angove, M. J.; Wells, J. D.; Johnson, B. B. “Aqueous Solubilities of Estrone,
17b-Estradiol, 17a-Ethynylestradiol, and Bisphenol A”. Journal of Chemical and
Engineering Data 2006, 51 (3), 879.

xxi

Rivollier, F.; Krebs, M.-O.; Kebir, O. “Perinatal Exposure to Environmental Endocrine
Disruptors in the Emergence of Neurodevelopmental Psychiatric Diseases: A
Systematic Review”. International Journal of Environmental Research and Public
Health 2019, 16 (8), 1318–1318 DOI: 10.3390/ijerph16081318.

xxii

Rodriquez-Bermejo, J.; Barreiro, P; Robla, J.I.; Ruiz-Garcia, L. “Thermal Study of a
Transport Container”. Journal of Food Engineering, 2007, 80 (2), DOI:
10.1016/j.jfoodeng.2006.06.010.

xxiii

Rottinghaus, M. “Effects of Temperature & pH on BPA leaching in Oral Hygiene
Products using Fluorescence Spectroscopy”.

Bynum 30

xxiv

Repouskou, A.; Konstantina Papadopoulou, A.; Panagiotiou, E.; Trichas, P.; Lindh, C.;
Bergman, A.; Gennings, C.; Bornehag, C.; Ruegg, J.; Kitraki, E.; Stamatakis, A.
“Long term transcriptional and behavioral effects in mice developmentally exposed to
a mixture of endocrine disruptors associated with delayed human neurodevelopment”.
Scientific Reports, 2020, 10 (1), DOI:10.1038/s41598-020-66379-x.

xxv

The Understood Team; “Learning disability by the numbers”.
https://www.understood.org/en/articles/learning-disabilities-by-the-numbers, 2014.

xxvi

United States Environmental Protection Agency; “America’s Children and the
Environment: Health- Neurodevelopmental Disorders”.
https://www.epa.gov/americaschildrenenvironment/ace-health-neurodevelopmentaldisorders, 2019.

xxvii

Varshney, M.; Nalvarte, I. “Genes, Gender, Environment, and Novel Functions of
Estrogen Receptor Beta in the Susceptibility to Neurodevelopmental
Disorders”. Brain Sciences 2017, 7 (12), 24–24 DOI: 10.3390/brainsci7030024.

xxviii

Wahab, M.F. “Fluorescence Spectroscopy in Shoebox”. Journal of Chemical Education
2007, 84 (8), 1308-1312.

xxix

Wang, Z; Yang, R; Xu, G; Liu, T; Wang, Q. “Chemical Upcycling of Poly(bisphenol A
carbonate) Plastic Catalyzed by ZnX2 via an Amino-Alcoholysis Strategy”. ACS
Sustainable Chemistry & Engineering 2022, 10, 4529-4537 DOI:
10.1021/acsuschemeng.1c08408.

Bynum 31

